Project Timeline: 14–30 working days
Applicable to: ELSRA official website, public publications, event materials, external cited records & third-party indexed content
1. Core Compliance Policies (Publish on Website)
1.1 Research Integrity Policy
- All life science research, papers, reports and statements must uphold scientific integrity. No falsification, fabrication, plagiarism or tampering with research data is allowed.
- All authors, researchers, reviewers and advisory experts must follow standardized research methodologies and record complete original data.
- Any suspected research misconduct will be investigated formally; relevant content will be taken offline pending review.
- All collaborative research shall retain complete experiment records, source data and review files for audit.
1.2 Universal Medical & Health Disclaimer (Display on All Health-Related Pages)
Standard notice (fixed text):
All content related to life science, health indicators, experimental observations and research results is for academic research and reference purposes only. It does not constitute medical advice, medical diagnosis, clinical treatment guidance or healthcare recommendations. Please consult licensed medical professionals for personal health issues.
1.3 Advertising & Commercial Claims Review Policy
- Strictly prohibit unsubstantiated medical efficacy claims, therapeutic effect statements and exaggerated health descriptions across all site content.
- Banned expressions: cure, treat, heal, prevent disease, medical efficacy, clinical cure and similar medical promotional wording.
- All content referencing products, supplements (including probiotics), commercial partners or sponsored research must go through pre-publication review before release.
- No unauthorized use of words such as
official,authoritative,accredited,certifiedto imply official regulatory recognition or medical qualification.
1.4 Conflict of Interest (COI) Disclosure for Commercial & Sponsored Research
- Any research, report, article or event supported by commercial organizations, product brands or third-party funders must add an explicit COI disclosure statement.
- Disclosure shall clearly state funding sources, commercial partners and potential relevant interests.
- Researchers and authors with commercial ties to tested products must declare interests publicly; those with major conflicts will be recused from related work.
2. Full Content Audit Workflow (Website + External Public Records)
Phase 1: Full Content Scan (Days 1–10)
Scope of inspection:
- All website pages: homepage, About, Events, Publications, Advisory, Membership, Blog, FAQ
- External public records: indexed papers, probiotics & health indicator research records, third-party archived content
Items to mark & categorize:
- Health claims: Any description linking research results to physical health effects, body indicators or healthcare functions
- Official claims: Overuse of “official”, “authoritative”, “recognized” and similar titles
- Accreditation & certification claims: Statements implying formal qualification, medical certification or regulatory approval
- Unreviewed commercial content: Product-related research, brand-linked content without COI disclosure
Phase 2: Revision & Remediation (Days 11–22)
- Add the standard medical disclaimer to every page containing health/life science research content.
- Remove or rephrase all unsubstantiated medical efficacy descriptions and exaggerated claims.
- Modify improper
official/ accreditation statements; keep only factual organizational descriptions. - Append mandatory COI disclosure to all product-related, commercially funded research and articles.
- Archive or revise external public papers/records with non-compliant claims; add supplementary disclaimers where applicable.
Phase 3: Final Verification & Lock (Days 23–30)
- Recheck all revised pages and external indexed content one by one.
- Confirm no prohibited claims remain; all required disclaimers and COI statements are fully displayed.
- Document all revised items for compliance archive.
3. Pre-Release Review Process (Long-term Mechanism)
All new content (articles, papers, event speeches, blog posts, announcements) must pass this review before publication:
- Submit draft to internal review team
- Check 3 key items: health/medical claims, official/accreditation wording, commercial funding & COI
- Request revision for non-compliant content
- Approve and publish only after full compliance
- Keep review records permanently
4. Standard Disclosure Templates (Direct Use)
Template 1 – Medical Disclaimer (Short Version for Sidebar/Footer)
Disclaimer: All life science research content is for academic reference only. Not medical advice.
Template 2 – COI Disclosure for Sponsored / Product-Related Research
Conflict of Interest Disclosure: This research is supported by [Funder/Partner Name]. The authors declare all relevant commercial relationships. All findings are for academic discussion only.
Template 3 – Statement for Removing “Official” Overstatements
Revise expressions to factual descriptions:
❌ Improper: Official medical guidance / Officially certified standard
✅ Correct: ELSRA academic research outcome / Internal research standard for reference
5. Contact for Compliance Issues
For content review, compliance enquiries and misconduct reports:
Service@elsra.org
